NHC:NYE-National HealthCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 134.43

Change

0.00 (0.00)%

Market Cap

USD 2.08B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-09 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-7.46 (-2.08%)

USD 89.71B
THC Tenet Healthcare Corporation

-2.64 (-1.58%)

USD 15.44B
UHS Universal Health Services Inc

-3.32 (-1.59%)

USD 13.69B
DVA DaVita HealthCare Partners Inc

+3.56 (+2.30%)

USD 11.58B
EHC Encompass Health Corp

-0.67 (-0.65%)

USD 10.27B
CHE Chemed Corp

+3.49 (+0.62%)

USD 7.97B
CON Concentra Group Holdings Paren..

+0.58 (+2.95%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.17 (-0.98%)

USD 2.59B
BKD Brookdale Senior Living Inc

-0.27 (-4.71%)

USD 1.14B
AMN AMN Healthcare Services Inc

-1.71 (-6.15%)

USD 1.06B

ETFs Containing NHC

COAL Exchange Traded Concepts .. 4.86 % 0.00 %

-0.74 (-3.06%)

USD 0.01B
ISPA:XETRA iShares STOXX Global Sele.. 2.25 % 0.00 %

-0.40 (-3.06%)

USD 2.30B
SDGPEX:SW iShares STOXX Global Sele.. 2.12 % 0.00 %

N/A

N/A
D100:XETRA MULTI-UNITS LUXEMBOURG - .. 2.08 % 0.00 %

-2.74 (-3.06%)

USD 0.04B
CGV Two Roads Shared Trust 1.93 % 0.00 %

-0.11 (-3.06%)

USD 0.11B
MVS:AU VanEck Vectors Small Comp.. 1.90 % 0.00 %

N/A

USD 0.07B
DESC 0.00 % 0.30 %

N/A

N/A
KOL 0.00 % 0.60 %

N/A

N/A
RNSC First Trust Small Cap US .. 0.00 % 0.60 %

-0.34 (-3.06%)

USD 0.03B
ISPA:F iShares (DE) I - iShares .. 0.00 % 0.00 %

-0.13 (-3.06%)

N/A
AFSM First Trust Active Factor.. 0.00 % 0.00 %

-0.58 (-3.06%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 45.46% 70% C- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.46% 70% C- 88% B+
Trailing 12 Months  
Capital Gain 87.25% 78% C+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 87.25% 78% C+ 90% A-
Trailing 5 Years  
Capital Gain 61.79% 78% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.79% 78% C+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.52% 61% D- 75% C
Dividend Return 17.69% 61% D- 77% C+
Total Return 3.17% 100% F 66% D+
Risk Return Profile  
Volatility (Standard Deviation) 35.82% 61% D- 28% F
Risk Adjusted Return 49.39% 87% B+ 66% D+
Market Capitalization 2.08B 62% D 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.